Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomodulatory Effect of Tranexamic Acid in TKA
NCT03795649Unknown
- Sponsor
- Mercy University Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tranexamic acid in hemorrhage (4 arms), sponsored by Mercy University Hospital. Primary endpoint: The immunomodulation effect of Tranexamic Acid at 2 years. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03795649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03795649.